Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND:   The Committee on Safety of Medicines (CSM) and National Institute for Health and Clinical Excellence have issued guidance on antidepressant use in depression in young people. METHOD:   An anonymous survey was sent to 692 UK consultants in child and adolescent psychiatry; the response rate was 70.1%. RESULTS:   Almost all (95.1%) respondents said fluoxetine was their antidepressant of first choice (29.9% only prescribed fluoxetine), although use of sertraline and citalopram was common. The CSM advice had resulted in 68.4% switching to fluoxetine only, or mostly. CONCLUSIONS:   Clinicians appear to be adhering national guidance. Guidance needs to be regularly updated to reflect current evidence.

Original publication




Journal article


Child Adolesc Ment Health

Publication Date





79 - 85


Survey, adolescents, antidepressants, children, major depression, young people